# FDA Inspection 1130875 - Averitas Pharma, Inc. - September 16, 2020

Source: https://www.keypedia.com/records/fda_inspections/averitas-pharma-inc/3c80618d-aa63-4893-8fbc-a38900bca787
Source feed: FDA_Inspections

> FDA Inspection 1130875 for Averitas Pharma, Inc. on September 16, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1130875
- Company Name: Averitas Pharma, Inc.
- Inspection Date: 2020-09-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/averitas-pharma-inc/e5b96e45-1356-4936-9654-a905227c1ecd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c